Drive Compliance with the 340B Program
March 2017 - Vol. 14 No. 3 - Page #2

The 340B Drug Pricing Program, administered by the Office of Pharmacy Affairs (OPA) under the Health Resources and Services Administration (HRSA), requires drug manufacturers participating in the Medicaid program to provide covered outpatient drugs to certain covered entities (CEs) at a reduced price. Eligible entities may receive significant drug cost savings, but must comply with all regulations. In particular, CEs must ensure that 340B medications are only dispensed to eligible patients and must take measures to prevent diversion.

To read the full article, please log in or register.

Current Issue

Our mission is to provide health system professionals with information to streamline operations and promote patient safety.

As a requester to PP&P you will receive all monthly issues, as well as our annual Resource Guide of product and service providers and all of our timely supplements on hot-button issues.

Thank you for reading PP&P, and we look forward to providing you with information to enhance the field.